Targeted Strategies for Today's Evolving Markets

MissionIR Blog

CombiMatrix (CBMX) Presents at Rodman & Renshaw Conference

CombiMatrix Corp. (NASDAQ: CBMX) is a clinical diagnostic laboratory specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. As a full-scale cytogenetic and cytogenomic laboratory, CombiMatrix offers chromosomal microarray analysis, standard and customized FISH, and high resolution karyotyping to help clinicians better care for their patients. CombiMatrix’s operations are made possible due, in large part, to the clinical and molecular diagnostic expertise of its medical team, and the technical expertise of our scientists and laboratory technicians. For more information, visit the company’s website at

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Comments are closed.